Weekend
Report - JNJ - Johnson and Johnson PriceWatch Alert With 12.14% Downside
Protection - Sourced WhisperFromWallStreet.com
WhisperfromWallStreet.com is a FREE award winning newsletter that specializes
in sending alerts to our subscribers on stocks we think are going to run, why
we think so, as well as teaching you how to become a better trader. We scan
hundreds of stocks a day to find those that meet our criteria and when we find
one, we send you an alert. We have sent out 40 alerts so far in 2009 with an
average price gain of over 80%. Please join risk free and see for yourself.
Sign up for our FREE alerts at WhisperfromWallStreet.com
---
JOHNSON AND JOHNS DC,JNJ
After Hours: 56.60 0.00 (0.00%) 6:46PM ET
Johnson and Johnson closed at $55.20. So far the stock has hit a 52-week low of
$46.25 and 52-week high of $72.76. Johnson and Johnson stock has been showing
support around 54.11 and resistance in the 56.07 range. Technical indicators
for the stock are Bullish and S&P gives JNJ a positive 4 STAR (out of 5)
buy rating. JNJ appears on the Investors Observer Hedged Dividend Income list.
For a hedged play on this stock, look at a Jan '10 50 covered call (JNJ AJ) for
a net debit in the $48.50 area. That is also the break even stock price for
this trade. This covered call has a 212 day duration, provides 12.14% downside
protection and a 3.09% assigned return rate for a 5.32% annualized return rate
(comparison purposes only). A lower cost hedged play for this stock would use a
longer term call option in place of the covered call stock purchase. To use
this strategy look at going long the JNJ Jan '10 45 Call (JNJ AI) and selling
the Jan '10 50 call (JNJ AJ) for a $4.15 debit.
About
Johnson & Johnson is engaged in the research and development, manufacture
and sale of a range of products in the healthcare field. Johnson & Johnson
has more than 250 operating companies. The Company operates in three segments:
Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer
segment includes a range of products used in the baby care, skin care, oral
care, wound care and women’s healthcare fields, as well as nutritional and
over-the-counter pharmaceutical products. The Pharmaceutical segment includes
products in the therapeutic areas, such as anti-infective, antipsychotic,
cardiovascular, contraceptive, dermatology, gastrointestinal, hematology,
immunology, neurology, oncology, pain management, urology and virology.
Last Trade: 56.60
Day's Range: 55.65 - 56.60
52wk Range: 46.25 - 72.76
Volume: 32,298,194
---
Here are a few alerts our WhisperfromWallStreet.com
subscribers enjoyed.
SPNG 1000%
AMNG 241%
RKBD 300%
UTRM 169%
TLLE 266%
Sign up to receive free stock alerts
---
Disclaimer: Full disclaimer at http://whisperfromwallstreet.com/disclaimer.php
WhisperfromWallStreet.com (WFWS) based upon information believed to be reliable
herein prepared all material. The information contained herein is not
guaranteed by WFWS to be accurate, and should not be considered to be
all-inclusive. The companies that are discussed in this opinion have not
approved the statements made in this opinion. This opinion contains
forward-looking statements that involve risks and uncertainties. This material
is for informational purposes only and should not be construed as an offer or
solicitation of an offer to buy or sell securities. WFWS is not a licensed
broker, broker dealer, market maker, investment banker, investment advisor,
analyst or underwriter. Please consult a broker before purchasing or selling
any securities viewed on http://www.whisperfromwallstreet.com or mentioned
herein. WFWS may have been compensated with shares or with cash from third
party shareholders or the company on behalf of one or more of the companies
mentioned in this opinion.
This release contains "forward-looking statements" within the meaning
of Section 27A of the Securities Act of 1933, as amended, and Section 21E the
Securities Exchange Act of 1934, as amended and such forward-looking statements
are made pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. "Forward-looking statements" describe
future expectations, plans, results, or strategies and are generally preceded
by words such as "may", "future", "plan" or
"planned", "will" or "should",
"expected," "anticipates", "draft",
"eventually" or "projected". You are cautioned that such
statements are subject to a multitude of risks and uncertainties that could
cause future circumstances, events, or results to differ materially from those
projected in the forward-looking statements, including the risks that actual
results may differ materially from those projected in the forward-looking
statements as a result of various factors, and other risks identified in a
companies' annual report on Form 10-K or 10-KSB and other filings made by such
company with the Securities and Exchange Commission. You should consider these
factors in evaluating the forward-looking statements included herein, and not
place undue reliance on such statements. The forward-looking statements in this
release are made as of the date hereof and WFWS undertakes no obligation to
update such statements.
This is not a solicitation to buy or sell any securities.
WhisperfromWallStreet.com, nor any of its affiliates are not registered
investment advisors or a broker dealers. Never invest in any stock featured on
our site or emails unless you can afford to lose your entire investment.
CONTACT: WhisperFromWallStreet.com
